about
Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.A new mouse model for renal lesions produced by intravenous injection of diphtheria toxin A-chain expression plasmidCurrent progress in gene delivery technology based on chemical methods and nano-carriersNew directions in liposome gene delivery.Lipoplexes and tumours. A review.Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipidCD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.Gene therapy in wound repair and regeneration.Vehicles for oligonucleotide delivery to tumours.Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes.Myths concerning the use of cationic liposomes in vivo.Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development.On the delivery of small interfering RNAs into mammalian cells.Evaluation of New Fluorescent Lipophosphoramidates for Gene Transfer and Biodistribution Studies after Systemic AdministrationOptimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.Role of calcium in gene delivery.Liposome-nucleic acid immunotherapeutics.Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.In vivo expression of neutrophil inhibitory factor via gene transfer prevents lipopolysaccharide-induced lung neutrophil infiltration and injury by a beta2 integrin-dependent mechanism.Lipid-based nanotherapeutics for siRNA deliveryGene therapy for ALI/ARDS.Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.Visualizing gene expression in living mammals using a bioluminescent reporter.Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes.Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.Systemic co-administration of depsipeptide selectively targets transfection enhancement to specific tissues and cell types.Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.Gene transfer mediated by sphingosine/ dioleoylphosphatidylethanolamine liposomes in the presence of poloxamer 188.Systemic administration of naked DNA with targeting specificity to mammalian kidneys.Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene deliveryPlasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.DNA vaccines for cancer therapy.Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs.Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery.Improved DNA: liposome complexes for increased systemic delivery and gene expression.Systemic gene delivery expands the repertoire of effective antiangiogenic agents.Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.Time-dependent reversal of sepsis-induced PMN uptake and lung vascular injury by expression of CD18 antagonist.
P2860
Q24797850-ECCD351F-EF93-4B1A-8AFE-C78AEAFB3139Q24804413-A839EC27-288E-4600-8F9B-7B9F9A920975Q28659480-425CA001-974E-40F2-B499-9D84FF8D8748Q33721388-8F98089E-15FF-4A3B-917B-75FA74DB29DEQ33723073-D303129A-341B-4237-8C29-4AE6356977A1Q33732824-69137514-C137-4B99-B9E2-52CB3D354AC0Q33941782-ABC1481E-4D03-4407-A0D5-9F7ADA6ED536Q33943864-F86896D6-591C-4A7F-A284-AFFFD9614E4CQ34156741-E0BF8C88-B365-446D-9025-8A7EEAF78D6BQ34518719-C520C432-3FAC-41E9-917E-2C7BF9E6B33FQ35071617-08C912C3-C160-4EE9-BEAB-5D0BE5044363Q35116145-3C6CF2E7-EF69-415A-B3A6-107D9C41A221Q35904455-42CDA1ED-A13A-4DEC-BC51-19CE6043E8B0Q36316859-4A760CCD-32A1-4C2F-B478-DBA1343FC36CQ36324477-EEE543D4-9462-4B4C-A153-B2616F8E6798Q36334067-92979F8C-FEBC-45DC-99CA-AACE5D942FBEQ36409049-A558C7D1-2F5A-409C-BEC8-97DB77BBB5B7Q36517160-7701D4A9-84B6-477F-87CC-266F97DB3D6FQ37167336-0F30E7D8-AD0B-4FF2-89AF-22490E8419DAQ37253992-FA69E504-AB7A-4DB3-8C64-78B5C58725F5Q37382637-E2134B31-315D-4FDC-A915-9DFC0BE2E913Q37670986-DC4DDEC9-2B10-48C6-B500-CABE6C3FFA47Q37899551-FCCBD440-6300-46F1-8CA4-ABC205FD0854Q38513773-8CD03588-B736-4686-A721-A5FB36D7A158Q38555717-8D4B8098-E033-4052-B5F0-CA956662857FQ39628648-7360D6DC-7821-4C0E-8D4F-C6311C6EB411Q39913293-3E9FBAAD-C893-4568-9D7E-2701C4C0F499Q40248360-552532E5-A602-4E32-B4D5-CEDC1B0FB78FQ40255867-8255D9B8-0B17-42ED-BFEE-217D8B63160FQ40332360-4B2770C9-8331-4601-830C-CA74D991CE82Q40472167-0EE28F78-FA33-4881-BFDB-55E192564BEBQ40598735-0DA7799B-197D-4F4B-896B-FA4B63D6BFA2Q40656536-47B09815-CC33-4CB7-856C-F56C254F35FBQ40732047-D6FA58E5-880C-4906-8A2E-2F01D3807FF1Q40905791-3EEBBBA7-3711-497F-9E9C-C6E678FE231DQ41130823-D3AA92B2-F7B4-4231-B2F4-777EE4EC79E4Q41633695-3A087588-AC24-416D-9E06-DAB5BB4AC5E1Q41649129-3D6EA91C-2F0C-485B-B57C-212FB50CAE5DQ41741739-E690BBCF-0923-42AD-9B35-54F3389AA6FFQ42518261-362D4E34-FAE7-41E5-90AE-9D9A74D70744
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Cationic liposome-mediated intravenous gene delivery.
@en
Cationic liposome-mediated intravenous gene delivery.
@nl
type
label
Cationic liposome-mediated intravenous gene delivery.
@en
Cationic liposome-mediated intravenous gene delivery.
@nl
prefLabel
Cationic liposome-mediated intravenous gene delivery.
@en
Cationic liposome-mediated intravenous gene delivery.
@nl
P2093
P2860
P356
P1476
Cationic liposome-mediated intravenous gene delivery.
@en
P2093
P2860
P304
24864-24870
P356
10.1074/JBC.270.42.24864
P407
P577
1995-10-01T00:00:00Z